Nanomedicine Targeted Delivery Of Therapeutics To The Placenta To Treat Preeclampsia

Grant number: 1127536 | Funding period: 2017 - 2020

Active

Abstract

Preeclampsia, one of the most serious complications of pregnancy, affects around 3-8% of all pregnancies. Sadly, there is no treatment. We have developed a new technique to deliver treatments only to the placenta, sparing the mother and baby from side effects. We will test whether this technique can treat the source of preeclampsia, the placenta, in human and mouse models in our laboratory. This work has potential to offer possibilities of new treatments to other pregnancy complications.